Looking for a new way to manage your ulcerative colitis?
Ulcerative Colitis (UC)
This Eli-Lily and Company Ulcerative Colitis research study is for adults struggling with moderate to severe active ulcerative colitis and have had an inadequate response to, loss of response to, or intolerance to at least 1 conventional or advanced therapy for UC. This study aims to seek out potential new ways to help with this condition.
Study information:
Condition: Ulcerative Colitis
Location: Las Vegas, Nevada
Duration: Up to 114 weeks
Participation: Up to 22 visits
Compensation: Up to $1,760
Eligibility:
Age 18 to 80 years old
Documented diagnosis of UC for at least 3 months
Have moderately to severely active UC
Willing to undergo an endoscopy
Other study requirements apply.
Participants may receive:
Compensation up to $5,766
Regular health check-ins with a physician to monitor symptoms and your health
Tests and procedures at no-cost to you
Access to a potential new treatment option for Ulcerative Colitis
Get started today.
You are not committed to participate in a study by completing this form. Participation is voluntary, and you may leave at any time if you change your mind.
What is Ulcerative Colitis (UC)?
Ulcerative colitis (UC) is a type of health condition known as Inflammatory Bowel Disease, or IBD. IBD causes changes in your immune system that can make your gut become inflamed or swollen. Ulcerative colitis is a long-term health condition that causes parts of your large intestine to become inflamed or sore.
Most common UC symptoms:
Diarrhea
Blood in stool
Bowel urgency
Stomach pain or cramps
Fatigue
Losing weight

